Fingerprint
Dive into the research topics of 'p38 MAPK inhibition enhances PS-341 (bortezomib)-induced cytotoxicity against multiple myeloma cells'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
p38 MAPK inhibition enhances PS-341 (bortezomib)-induced cytotoxicity against multiple myeloma cells
Teru Hideshima, Klaus Podar, Dharminder Chauhan, Kenji Ishitsuka, Constantine Mitsiades, Yu-Tzu Tai, Makoto Hamasaki, Noopur Raje, Hiromasa Hideshima, George Schreiner, Aaron N Nguyen, Tony Navas, Nikhil C Munshi, Paul G Richardson, Linda S Higgins, Kenneth C Anderson
Research output: Journal article (peer-reviewed) › Journal article
114
Citations
(Scopus)